KIRN DAVID has a total of 14 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are JENNEREX INC, HUAIAN KANGYILAI STEM CELL BIOTECHNOLOGY CO LTD and LEIDS UNI MEDISCH CT.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture | |
#4 | Measurement | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Animal care | |
#6 | Electrotherapy | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Kirn David | 14 |
#2 | Thorne Steve H | 3 |
#3 | Bell John | 3 |
#4 | Breitbach Caroline | 2 |
#5 | Hwang Tae-Ho | 1 |
#6 | Kim Mi-Kyung | 1 |
#7 | Lee Yu Kyoung | 1 |
#8 | Moon Anne | 1 |
Publication | Filing date | Title |
---|---|---|
US2012276053A1 | Oncolytic vaccinia virus cancer therapy | |
US2010303714A1 | Oncolytic vaccinia virus cancer therapy |